Technical Analysis for MBIO - Mustang Bio, Inc.

Grade Last Price % Change Price Change
grade D 8.86 -4.32% -0.40
MBIO closed down 4.32 percent on Wednesday, April 25, 2018, on 76 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical MBIO trend table...

Date Alert Name Type % Chg
Apr 25 Lower Bollinger Band Walk Weakness 0.00%
Apr 25 Stochastic Reached Oversold Weakness 0.00%
Apr 25 Below Lower BB Weakness 0.00%
Apr 25 Down 3 Days in a Row Weakness 0.00%
Apr 25 Down 4 Days in a Row Weakness 0.00%
Apr 25 Down 5 Days in a Row Weakness 0.00%
Apr 25 Lower Bollinger Band Touch Weakness 0.00%
Apr 25 Oversold Stochastic Weakness 0.00%
Apr 24 Lower Bollinger Band Walk Weakness -4.32%
Apr 24 Below Lower BB Weakness -4.32%

Older signals for MBIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
Is MBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.35
52 Week Low 8.055
Average Volume 87,084
200-Day Moving Average 0.0
50-Day Moving Average 10.7564
20-Day Moving Average 10.207
10-Day Moving Average 9.86
Average True Range 0.5967
ADX 23.16
+DI 8.97
-DI 24.28
Chandelier Exit (Long, 3 ATRs ) 9.7099
Chandelier Exit (Short, 3 ATRs ) 10.5701
Upper Bollinger Band 11.3467
Lower Bollinger Band 9.0673
Percent B (%b) -0.09
BandWidth 22.331733
MACD Line -0.4363
MACD Signal Line -0.3193
MACD Histogram -0.117
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.76
Resistance 3 (R3) 9.83 9.61 9.61
Resistance 2 (R2) 9.61 9.38 9.57 9.56
Resistance 1 (R1) 9.23 9.24 9.12 9.16 9.51
Pivot Point 9.01 9.01 8.95 8.97 9.01
Support 1 (S1) 8.63 8.78 8.52 8.56 8.21
Support 2 (S2) 8.41 8.64 8.37 8.16
Support 3 (S3) 8.03 8.41 8.11
Support 4 (S4) 7.96